Naftin (Naftifine) is an antifungal medicine for the treatment of tinea infections that is available as a cream and gel for topical appplication.
Naftin (Naftifine) Uses:
-
Tinea infections:
- Tinea cruris (also known as jock itch), tinea corporis (also known as ringworm), and tinea pedis (also known as athlete's foot) infections can all be treated with topical creams of 1%, 2%, and gel of 1%.
-
Tinea pedis:
- Topical Gel 2% is indicated for the treatment of tinea pedis (athlete's foot).
Naftin (Naftifine) Dose in Adults
Naftin (Naftifine) Dose in the treatment of Tinea corporis and tinea cruris:
- Cream 1% and gel 1%:
- Apply the gel topically twice daily (in the morning and evening) to the skin around the afflicted region and apply the cream topically once daily for up to four weeks.
- Cream 2%:
- For two weeks, apply a thin coating of the cream to the afflicted region and the healthy skin all around it.
Naftin (Naftifine) Dose in the treatment of Tinea pedis:
- Cream 1% and gel 1%:
- For up to four weeks, use the cream once daily or the gel twice daily in the morning and the evening to the afflicted region and the surrounding skin.
- Cream 2% and gel 2%:
- For two weeks, apply a light coating once daily to the afflicted region and the skin around it.
Naftin (Naftifine) Dose in Children
Naftin (Naftifine) Dose in the treatment of Tinea corporis:
- Children older than 2 years and Adolescents:
- Topical Cream 2%:
- Refer to adult dosing.
- Topical Cream 2%:
Naftin (Naftifine) Dose in the treatment of Tinea cruris, tinea pedis:
- Children ≥12 years and Adolescents:
- Topical: Cream 2%:
- Refer to adult dosing.
- Topical: Cream 2%:
Naftin (Naftifine) Dose in the treatment of Tinea pedis:
- Children ≥12 years and Adolescents:
- Topical: Gel 2%:
- Refer to adult dosing.
- Topical: Gel 2%:
Pregnancy Risk Category: B
- In animal reproduction studies, adverse fetal outcomes weren't observed when the drug had been taken orally.
- After topical application, 4 to 6% of the drug can be absorbed systemically.
Use of Naftifine while breastfeeding
- It is unknown if the drug will be excreted into breast milk.
- The manufacturer suggests weighing the benefits to the mother and the risks to her infant.
Naftin (Naftifine) Dose in Kidney Disease:
The manufacturer has not recommended any adjustments in the dose in patients with kidney disease.
Naftin (Naftifine) Dose in Liver disease:
The manufacturer has not recommended any adjustments in the dose in patients with liver disease.
Side Effects of Naftin (Naftifine):
-
Local:
- Application site reaction
-
Dermatologic:
- Skin Irritation
- Erythema
- Burning Sensation Of Skin
- Xeroderma
- Pruritus
Contraindications to Naftin (Naftifine):
Allergy reactions to naftifine and any component of this formulation
Warnings and precautions
-
Irritation
- If irritation or hypersensitivity is observed, discontinue use.
- If you notice a reaction, please immediately treat it.
Monitoring parameters:
- Follow culture and KOH exam
- re-assess if no improvement is noticed after four weeks of therapy
How to administer Naftin (Naftifine)?
- It is intended for topical use only. Avoid applying over nasal, ophthalmic, oral, or vaginal mucosa.
- Apply to clean and dry skin and do not use occlusive dressings. Wash hands before and after use.
Mechanism of action of Naftin (Naftifine):
- It is a synthetic antifungal drug with broad-spectrum antifungal properties.
- It dose-dependently inhibits squalene-epoxidase while preferentially avoiding other enzymes.
- As a result, there is a decrease in the production of ergosterol, which is an important component of fungi's cell membranes. Additionally, it raises the enzyme content of fungus cells.
Half-life elimination:
- 2 to 3 days
Systemic Absorption:
- Gel: 4%
- Cream: 6%
Excretion: Urine and faeces (as unchanged drug and/or metabolites)
International Brands of Naftifine:
- Naftin
- A Mei
- Chizocin
- Exo-Derm
- Exoderil
- Fang Di
- Fetimin
- Jia Met
- Suadian
Naftifine Brand Names in Pakistan
Naftifine Solution 1 % W/V |
|
Exoderil | Novartis Pharma (Pak) Ltd |
Naftifine Cream 1 % W/W |
|
Caraderil | Caraway Pharmaceuticals |
Caraderil | Caraway Pharmaceuticals |
Exoderil | Novartis Pharma (Pak) Ltd |
Litin | Linear Pharma |
Naftifine Cream 1 % W/W |
|
Disalpin | Akhai Pharmaceuticals. |